{"organizations": [], "uuid": "6b1da5c1da501cc8a35a22ec2795a0bc078168cb", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180124.html", "section_title": "Archive News &amp; Video for Wednesday, 24 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/buzz-accuray-rbc-jefferies-raise-pts-aft/buzz-accuray-rbc-jefferies-raise-pts-after-results-idUSL4N1PJ48D", "country": "US", "domain_rank": 408, "title": "BUZZ-Accuray: RBC, Jefferies raise PTs after results", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.007, "site_type": "news", "published": "2018-01-24T21:13:00.000+02:00", "replies_count": 0, "uuid": "6b1da5c1da501cc8a35a22ec2795a0bc078168cb"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/buzz-accuray-rbc-jefferies-raise-pts-aft/buzz-accuray-rbc-jefferies-raise-pts-after-results-idUSL4N1PJ48D", "ord_in_thread": 0, "title": "BUZZ-Accuray: RBC, Jefferies raise PTs after results", "locations": [], "entities": {"persons": [{"name": "akankshita mukhopadhyay", "sentiment": "none"}], "locations": [{"name": "bengaluru", "sentiment": "none"}], "organizations": [{"name": "rbc", "sentiment": "negative"}, {"name": "jefferies", "sentiment": "negative"}, {"name": "rbc capital markets", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "** Radiation and oncology device maker’s shares up 7.69 pct at $5.6 premarket\n** RBC Capital Markets and Jefferies raise PTs after company on Tuesday reports better-than-expected Q2 revenue and smaller loss\n** RBC raises PT to $6 from $5; Jefferies to $7 from $6\n** Management execution improving and new technology improvement on the way - RBC Capital Markets\n** 3 of 7 brokerages rate the stock “buy” or higher, 2 “hold” and 2 “sell” or lower; median PT is $7\n** Up to Tuesday’s close, stock had risen about 21 pct this year (Reporting by Akankshita Mukhopadhyay in Bengaluru)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-24T21:13:00.000+02:00", "crawled": "2018-01-25T13:16:05.037+02:00", "highlightTitle": ""}